100 related articles for article (PubMed ID: 24479356)
1. [Effect and safety analysis of Allergovit standardized mite allergen immunotherapy in patients with allergic rhinitis].
Zhao X; Wu H; Lin L; Liu Q; Li X; Luo B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2013 Oct; 27(20):1128-31. PubMed ID: 24479356
[TBL] [Abstract][Full Text] [Related]
2. [Efficacy and safety analysis with standardized mite allergen subcutaneous immunotherapy in 90 patients with allergic rhinitis].
Li L; Guan GM; Zhu DD; Sha JC; Jin GH; Chen MX; Zhang H; Dong Z
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Jun; 47(6):445-8. PubMed ID: 22932133
[TBL] [Abstract][Full Text] [Related]
3. Sublingual immunotherapy in children with allergic rhinoconjunctivitis mono-sensitized to house-dust-mites: a double-blind-placebo-controlled randomised trial.
Aydogan M; Eifan AO; Keles S; Akkoc T; Nursoy MA; Bahceciler NN; Barlan IB
Respir Med; 2013 Sep; 107(9):1322-9. PubMed ID: 23886432
[TBL] [Abstract][Full Text] [Related]
4. [Clinical efficacy of subcutaneous and sublingual immunotherapy in mite-sensitized patients with allergic rhinitis].
Zhu L; Zhu LP; Chen RX; Tao QL; Lu JH; Cheng L
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 46(12):986-91. PubMed ID: 22336009
[TBL] [Abstract][Full Text] [Related]
5. [Observation on the effect of the dust mite sublingual immunotherapy for allergic rhinitis].
Du X; Shu C; Xu G; Ma M; Song H
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Apr; 26(8):372-3. PubMed ID: 22730824
[TBL] [Abstract][Full Text] [Related]
6. [Effect of 1-year specific immunotherapy with standardized house dust mite vaccine on mild to moderate allergic asthmatic patients].
Wang HY; Lin XP; Hao CL; Zhang CQ; Sun BQ; Zheng JP; Chen P; Sheng JY; Wu A; Zhong NS
Zhonghua Jie He He Hu Xi Za Zhi; 2006 Oct; 29(10):679-87. PubMed ID: 17129496
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of sublingual immunotherapy in Asian children.
Park IH; Hong SM; Lee HM
Int J Pediatr Otorhinolaryngol; 2012 Dec; 76(12):1761-6. PubMed ID: 22959336
[TBL] [Abstract][Full Text] [Related]
8. [The effects of subcutaneous allergen immunotherapy by Alutard SQ allergy vaccination in management of perennial allergic rhinitis].
Fu Z; Lin X; Cai F; Wang G; Deng H; Li Q; Wang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Aug; 26(16):744-6. PubMed ID: 23213755
[TBL] [Abstract][Full Text] [Related]
9. [Safety analysis of Allergovit immunotherapy in patients of allergic rhinitis].
Chen J; Xiang J; Kong W; Shu H; Shi Q; Tan H
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2006 Mar; 20(5):208-9. PubMed ID: 16722392
[TBL] [Abstract][Full Text] [Related]
10. Simplified local nasal immunotherapy in mite dust allergic rhinitis.
Bellussi L; Bologna M; Di Stanislao C; Lauriello M; Mezzedimi C; Muzi P; Passàli GC; Passàli D
J Investig Allergol Clin Immunol; 2002; 12(1):42-7. PubMed ID: 12109531
[TBL] [Abstract][Full Text] [Related]
11. [The analysis of the efficacy of patients with allergic rhinitis treated with specific immunotherapy].
Ding J; Zhang J; Chen B
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2014 Mar; 28(5):293-6. PubMed ID: 25185279
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy of sublingual immunotherapy with dermatophagoides farinae drops in patients with allergic rhinitis].
Li TY; Chen DH; Lin ZB; Xu R
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Oct; 46(10):859-62. PubMed ID: 22321427
[TBL] [Abstract][Full Text] [Related]
13. Long-term efficacy of specific immunotherapy on house dust mite-induced allergic rhinitis in China.
Peng H; Li CW; Lin ZB; Li TY
Otolaryngol Head Neck Surg; 2013 Jul; 149(1):40-6. PubMed ID: 23569202
[TBL] [Abstract][Full Text] [Related]
14. [Study on safty of standardized specific mite-allergen immunotherapy to children with allergic rhinitis and/or asthma].
Wu Y; Long Z; Huang Y; Huang X
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Jul; 25(14):641-4. PubMed ID: 22032122
[TBL] [Abstract][Full Text] [Related]
15. Sublingual immunotherapy to house dust mite in pediatric patients with allergic rhinitis and asthma: a retrospective analysis of clinical course over a 3-year follow-up period.
Nuhoglu Y; Ozumut SS; Ozdemir C; Ozdemir M; Nuhoglu C; Erguven M
J Investig Allergol Clin Immunol; 2007; 17(6):375-8. PubMed ID: 18088019
[TBL] [Abstract][Full Text] [Related]
16. A double-blind randomized placebo-controlled trial with short-term beta-glucuronidase therapy in children with chronic rhinoconjunctivitis and/or asthma due to dust mite allergy.
Galli E; Bassi MS; Mora E; Martelli M; Gianni S; Auricchio G; Arabito E; Rossi P
J Investig Allergol Clin Immunol; 2006; 16(6):345-50. PubMed ID: 17153881
[TBL] [Abstract][Full Text] [Related]
17. Real-life compliance and persistence among users of subcutaneous and sublingual allergen immunotherapy.
Kiel MA; Röder E; Gerth van Wijk R; Al MJ; Hop WC; Rutten-van Mölken MP
J Allergy Clin Immunol; 2013 Aug; 132(2):353-60.e2. PubMed ID: 23651609
[TBL] [Abstract][Full Text] [Related]
18. [Clinical efficacy and safety of sublingual immunotherapy using standardized Dermatophagoides farinae extract for children with combined allergic rhinitis and asthma syndrome].
Wen CJ; Zhu MF; Ren WM; Liu XY; Qian H
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 May; 46(5):393-6. PubMed ID: 21781561
[TBL] [Abstract][Full Text] [Related]
19. [Efficacy and safety of sublingual immunotherapy with house dust mite extract in poly allergen sensitized children with allergic rhinitis].
Zhou L; Wang J; Chen Y; Luo R; Tao J; Nie M; Liu B; Li Y
Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2012 Oct; 26(20):913-6. PubMed ID: 23272490
[TBL] [Abstract][Full Text] [Related]
20. An evidence-based analysis of house dust mite allergen immunotherapy: a call for more rigorous clinical studies.
Calderon MA; Casale TB; Nelson HS; Demoly P
J Allergy Clin Immunol; 2013 Dec; 132(6):1322-36. PubMed ID: 24139829
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
